Cargando…
A network pharmacology approach for investigating the multi-target mechanisms of Huangqi in the treatment of colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is the third most prevalent cancer globally. In the treatment of CRC, surgical resection is commonly adopted, and neoadjuvant chemotherapy or immunotherapy is mainly administered for patients with advanced disease. However, despite the developments in the field of...
Autores principales: | Chu, Xiao-Dong, Zhang, Yi-Ran, Lin, Zheng-Bin, Zhao, Zhan, Huangfu, Shu-Chen, Qiu, Sheng-Hui, Guo, Yan-Guan, Ding, Hui, Huang, Ting, Chu, Xiao-Li, Pan, Jing-Hua, Pan, Yun-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798599/ https://www.ncbi.nlm.nih.gov/pubmed/35116401 http://dx.doi.org/10.21037/tcr-20-2596 |
Ejemplares similares
-
Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer
por: Chu, Xiao-dong, et al.
Publicado: (2022) -
System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus
por: Yue, Shi-Jun, et al.
Publicado: (2017) -
Network Pharmacology Analysis of Huangqi Jianzhong Tang Targets in Gastric Cancer
por: Li, Long, et al.
Publicado: (2022) -
Endostatin induces normalization of blood vessels in colorectal cancer and promotes infiltration of CD8+ T cells to improve anti-PD-L1 immunotherapy
por: Chu, Xiao-Dong, et al.
Publicado: (2022) -
Mechanism of Huangqi Sanxian Decoction Inhibiting Osteoclast Differentiation Based on Network Pharmacology
por: Shi, Jian-Xin, et al.
Publicado: (2022)